Clinical Trials Logo

Clinical Trial Summary

This study will assess the impact of providing medication abortion-seeking clients a choice for follow-up in practice. Clients presenting at or less than 63 days pregnant (based on last menstrual period) at the study site for first trimester medication abortion will be invited to participate. We hypothesize that providing clients with flexible follow-up options will improve follow-up rates.

This study is not to assess efficacy or safety of follow-up methods--that has been well established in practice and research. This is to assess choice of follow-up.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04056637
Study type Interventional
Source Stanford University
Contact
Status Terminated
Phase N/A
Start date September 9, 2019
Completion date March 31, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05896657 - Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713 N/A
Active, not recruiting NCT03736681 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage Phase 1
Completed NCT03636451 - Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o Phase 3
Completed NCT04446572 - Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin Phase 2
Not yet recruiting NCT03267771 - Progesterone and Doppler in Recurrent Abortion Phase 4
Recruiting NCT05341817 - The Use of Letrozole or Mifepristone for Pretreatment of Medical Termination of Pregnancy Phase 4
Completed NCT03079622 - Manual Versus Electric Vacuum Aspiration for Pregnancy Termination Between 10-14 Weeks N/A
Recruiting NCT05182008 - A Patient Decision Aid for Method of Early Abortion: A Randomized Control Trial N/A
Completed NCT03417362 - Delivery of Audiovisual Information on Early Medical Abortion N/A
Completed NCT03896022 - Auriculotherapy - Pain Management of Aspiration Abortion N/A
Completed NCT03925129 - Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Management With Medication Abortion Through 70 Days' Gestation N/A
Suspended NCT03751423 - Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion Phase 3
Completed NCT03480009 - Dextromethorphan as a Novel Non-opioid Adjunctive Agent for Pain Control in Medication Abortion Phase 3
Completed NCT05469594 - Second-trimester TOP : a Retrospective Study Comparing Complications at 12-14 vs 14-16 Weeks of Gestation
Enrolling by invitation NCT05320432 - Transcutaneous Electrical Nerve Stimulation for Pain Control During First-trimester Abortion N/A
Completed NCT03187002 - Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Control During First Trimester Abortion N/A
Terminated NCT04139382 - Using Telemedicine to Improve Early Medical Abortion at Home N/A
Recruiting NCT04956731 - Pharmacist Provision of Medication Abortion N/A
Recruiting NCT04336358 - Telemedicine for First Trimester Abortion in South Africa N/A
Completed NCT02096575 - Nitrous Oxide for Pain Management of First Trimester Surgical Abortion N/A